Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients-A Qualitative and Quantitative Approach. | Biomolecules | 2023 | 36979371 | PubTator, text mining | PubMed |
| Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. | Bioengineering (Basel) | 2023 | 36978745 | PubTator, text mining | PubMed |
| Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. | Front Immunol | 2023 | 36969193 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness-The central cue for skin fibrosis. | Front Mol Biosci | 2023 | 36968277 | PubTator, text mining | PubMed |
| A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases. | Cancer Res Commun | 2023 | 36968142 | PubTator, text mining | PubMed |
| Chemokines in patients with Alzheimer's disease: A meta-analysis. | Front Aging Neurosci | 2023 | 36967827 | PubTator, text mining | PubMed |
| Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma. | Exp Eye Res | 2023 | 36967081 | PubTator, text mining | PubMed |
| Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. | EBioMedicine | 2023 | 36966617 | PubTator, text mining | PubMed |
| Phylogenomic investigation of an outbreak of fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Paratyphi A in Phnom Penh, Cambodia. | Microb Genom | 2023 | 36961484 | PubTator, text mining | PubMed |
| Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function. | Int J Obes (Lond) | 2023 | 36959287 | PubTator, text mining | PubMed |
| Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments. | Front Immunol | 2023 | 36949948 | PubTator, text mining | PubMed |
| Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36949462 | PubTator, text mining | PubMed |
| Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction. | Radiol Med | 2023 | 36947276 | PubTator, text mining | PubMed |
| Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer. | Br J Cancer | 2023 | 36941406 | PubTator, text mining | PubMed |
| Characterization of immature ovarian teratomas through single-cell transcriptome. | Front Immunol | 2023 | 36936909 | PubTator, text mining | PubMed |
| Prognostic value of severe acute respiratory syndrome coronavirus-2 viral load and antibodies in patients hospitalized with COVID-19. | Clin Transl Sci | 2023 | 36929625 | PubTator, text mining | PubMed |
| The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. | Cell Mol Immunol | 2023 | 36928371 | PubTator, text mining | PubMed |
| CD300a Regulates Mouse Macrophage Functionality in Allergic Inflammation. | Int Arch Allergy Immunol | 2023 | 36928079 | PubTator, text mining | PubMed |
| Are genes the missing link to detect and prognosticate RA-ILD? | Rheumatol Adv Pract | 2023 | 36923263 | PubTator, text mining | PubMed |
| Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease. | Biochem Pharmacol | 2023 | 36921632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=40